Brief: S.BIOMEDICS Cell Therapy For Parkinson’s Disease With TED-A9 Shows Promising Results At 12 Months In Phase I/IIa Trial

S Biomedics

09/07/2024 12:27

July 9 (Reuters) - S Biomedics Co Ltd  304360.KQ :
    * S.BIOMEDICS DOPAMINE CELL THERAPY FOR PARKINSON’S DISEASE
WITH
TED-A9 SHOWS PROMISING RESULTS AT 12 MONTHS IN PHASE I/IIA
CLINICAL TRIAL
    * S BIOMEDICS CO LTD - NO MAJOR SAFETY ISSUES IN 3 LOW DOSE
PARTICIPANTS

Source text for Eikon:  ID:nBw2DsMqYa 
Further company coverage:  304360.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))